Bioleaders Corp. | Income Statement
Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Sales/Revenue
1,577
1,167
1,478
2,501
7,607
Cost of Goods Sold (COGS) incl. D&A
1,837
1,050
1,509
2,128
7,256
Gross Income
260
117
31
372
351
SG&A Expense
2,449
3,508
4,920
6,283
7,033
EBIT
2,709
3,391
5,043
6,002
6,826
Unusual Expense
648
108
13,491
18
36
Non Operating Income/Expense
483
2,911
73
41
213
Interest Expense
383
332
237
67
-
Pretax Income
3,256
698
18,639
5,896
6,647
Consolidated Net Income
3,221
1,361
18,639
5,896
6,647
Net Income
3,221
1,361
18,639
5,896
6,647
Net Income After Extraordinaries
3,221
1,361
18,639
5,896
6,647
Net Income Available to Common
3,262
1,418
18,639
5,896
6,647
EPS (Basic)
264.00
115.00
1,509.00
502.00
441.00
Basic Shares Outstanding
12
12
12
12
15
EPS (Diluted)
264.07
114.81
1,508.72
502.20
440.52
Diluted Shares Outstanding
12
12
12
12
15
EBITDA
1,963
2,727
4,540
5,573
6,210
Other Operating Expense
-
-
92
91
143
Non-Operating Interest Income
2
6
59
72
355
Preferred Dividends
41
57
-
-
-
About Bioleaders
View Profile
